Massachusetts is currently experiencing an increase in Hepatitis C and A infections. Between 2011 and 2015, Hepatitis C rates went up by 1,133%. Between April 2018 and January 2019, 285 cases of acute hepatitis A virus infection have been reported.
This three-hour long training introduces attendees to the anatomy and function of the liver and how to use harm reduction principles to combat the transmission of viral hepatitis. We also discuss treatment and management of viral hepatitis, including new treatment protocols. To learn more about this training, review the agenda.
At the conclusion of the training, participants will be able to:
- Describe workings of a healthy liver
- Explain how viral Hepatitis A, B, & C are transmitted
- Recite potential signs and symptoms of viral hepatitis
- Explain prevention strategies/vaccinations for viral hepatitis A, B & C
- Discuss harm reduction strategies for reducing transmission of viral hepatitis A, B & C
- Explain treatment and management of viral hepatitis A, B & C
- Explain differences between Interferon and Harvoni
- Demonstrate how to assess a client’s risks for acquiring a viral hepatitis infection
- Employ key discussion points for teaching clients about viral hepatitis